Nakamura Ken, Uchida Tetsuro, Hamasaki Azumi, Sadahiro Mitsuaki
Division of Cardiovascular Surgery Nihonkai General Hospital, 30 Akihochou, Sakata city, Yamagata, Japan.
Second Department of Surgery, Yamagata University Faculty of Medicine, Yamagata, Japan.
J Cardiothorac Surg. 2019 Feb 26;14(1):44. doi: 10.1186/s13019-019-0869-z.
Preemptive thoracic endovascular aortic repair (TEVAR) is an advanced treatment that has possibility to improve late outcomes in patients with subacute type B aortic dissection. However, it may not be the treatment of choice for elderly patients with uncomplicated subacute type B aortic dissection because of their inherent frailty and increased risk of periprocedural complications.
Data were collected between July 2004 and October 2017 in Yamagata university hospital and between February 2016 and May 2018 in Nihonkai General hospital. A total of 152 medically treated subacute type B aortic dissection patients were enrolled in this study. Patients were divided into two groups: age 80 year and older group (Group O, n = 33, 22%) and a group < 80 years of age (Group U, n = 119, 78%).
During follow-up, the incidence of adverse events was 27% (n = 9) in Group O and 37% (n = 44) in Group U (P = 0.409). The incidence of aortic rupture was 3% (n = 1), and the incidence of acute type A dissection was 3% (n = 1) in Group O. In Group O, only one patient (3%) died of aorto-bronchial fistula. The Group O patients had less surgical intervention (3 patients [9%] in Group O and 30 patients [25%] in Group U, P = 0.047), but aortic related death did not differ between the two groups. The 1-, 2-, and 5-year freedom from aorta-related death rates of Group O were 97, 97, and 97%, respectively, compared with 99, 94, and 91%, respectively, in Group U (P = 0.880).
Patients aged 80 years and older who underwent medical treatment for acute and subacute type B dissection had excellent outcomes in chronic phase. The elderly patients had less surgical intervention, but aortic related death did not differ from younger patients.
抢先性胸主动脉腔内修复术(TEVAR)是一种先进的治疗方法,有可能改善B型主动脉夹层亚急性期患者的远期预后。然而,对于无并发症的B型主动脉夹层老年患者,由于其自身身体虚弱以及围手术期并发症风险增加,它可能并非首选治疗方法。
收集了2004年7月至2017年10月在山形大学医院以及2016年2月至2018年5月在日本海综合医院的数据。本研究共纳入152例接受药物治疗的B型主动脉夹层亚急性期患者。患者被分为两组:80岁及以上组(O组,n = 33,22%)和80岁以下组(U组,n = 119,78%)。
随访期间,O组不良事件发生率为27%(n = 9),U组为37%(n = 44)(P = 0.409)。O组主动脉破裂发生率为3%(n = 1),急性A型夹层发生率为3%(n = 1)。在O组中,仅1例患者(3%)死于主动脉支气管瘘。O组患者接受手术干预的比例较低(O组3例[9%],U组30例[25%],P = 0.047),但两组间主动脉相关死亡率无差异。O组1年、2年和5年主动脉相关死亡率分别为97%、97%和97%,U组分别为99%、94%和91%(P = 0.880)。
接受药物治疗的80岁及以上急性和亚急性B型夹层患者在慢性期预后良好。老年患者接受手术干预较少,但主动脉相关死亡率与年轻患者无差异。